Cargando…
Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905818/ https://www.ncbi.nlm.nih.gov/pubmed/36761431 http://dx.doi.org/10.3389/fonc.2022.1115342 |
| _version_ | 1784883882400677888 |
|---|---|
| author | Zambelli, Alberto D’Incalci, Maurizio |
| author_facet | Zambelli, Alberto D’Incalci, Maurizio |
| author_sort | Zambelli, Alberto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9905818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99058182023-02-08 Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives Zambelli, Alberto D’Incalci, Maurizio Front Oncol Oncology Frontiers Media S.A. 2023-01-25 /pmc/articles/PMC9905818/ /pubmed/36761431 http://dx.doi.org/10.3389/fonc.2022.1115342 Text en Copyright © 2023 Zambelli and D’Incalci https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Zambelli, Alberto D’Incalci, Maurizio Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives |
| title | Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives |
| title_full | Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives |
| title_fullStr | Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives |
| title_full_unstemmed | Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives |
| title_short | Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives |
| title_sort | editorial: trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: mechanisms of action, clinical impact, and future perspectives |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905818/ https://www.ncbi.nlm.nih.gov/pubmed/36761431 http://dx.doi.org/10.3389/fonc.2022.1115342 |
| work_keys_str_mv | AT zambellialberto editorialtrabectedinlurbinectedinandothermarinederivedanticanceralkaloidsonsolidcancermechanismsofactionclinicalimpactandfutureperspectives AT dincalcimaurizio editorialtrabectedinlurbinectedinandothermarinederivedanticanceralkaloidsonsolidcancermechanismsofactionclinicalimpactandfutureperspectives |